Skip to content
AnalystLens

LAM RESEARCH CORP Annual Report, Year Ended Jun 24, 2007

Filing Date
Filed March 31, 2008
Period End
June 24, 2007
Security
LRCX
In the record · 2016–202610-K1110-Q328-K128

LRCX filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 128 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Oct ’16Oct ’16
  2. FY2019 annual report10-K · Aug ’19Aug ’19
  3. Leadership change8-K · Nov ’21Nov ’21
  4. Leadership change8-K · Nov ’25Nov ’25

Summary

Summary of the 10-K filed March 31, 2008. Cited figures are marked; the original filing is the authoritative source.

Lam Research's fiscal 2007 Form 10-K (filed March 31, 2008) is dominated by a restatement of historical stock option accounting, not by the operating story.

The company's operating performance was very strong: revenue rose 56% to $2.57 billiona, gross margin held above 50% for a third consecutive year at 50.8%, and operating margin expanded to 30.3% from 24.6%. Net income reached $685.8 million, or $4.85 per diluted share, and operating cash flow more than doubled to $823.6 million. Customer concentration was notable, with Hynix and Samsung each representing about 14% of revenue, and roughly 84% of revenue came from outside the United States.

The central investor concern is the stock option review. An independent committee examined grants from fiscal 1997 to 2005 and concluded that measurement dates for many grants differed from recorded grant dates. The company recorded $96.4 millionb in pre-tax incremental stock-based compensation and payroll tax expense ($65.8 million after tax), and it will also make employees whole for an estimated $50 to $55 million in potential Section 409A tax liabilities.

Management and the committee found no intentional misconduct. The filing also discloses a NASDAQ listing non-compliance issue arising from the late filings, shareholder demand letters, and loss of Form S-3 eligibility for one year, all of which add legal, financial, and governance risk. Balance sheet and capital allocation changed meaningfully during the year.

The company repurchased $1.08 billionc of stock, completing all authorizations, and its cash and short-term investments declined. It then took on a $250 million term loan in March 2008 and agreed to acquire roughly 94% of SEZ Holding AG for about $584 million, which was completed in March 2008.

Operating leases of roughly $165 milliond were also entered into for Fremont and Livermore facilities. Taken together, these items mean that future results will reflect the integration of SEZ, higher interest and lease obligations, and the outcome of the remaining governance and legal matters.

Key Highlights

  1. Record fiscal 2007 revenue of $2.57 billion, up 56% from $1.64 billion, with gross margin of 50.8% and operating margin of 30.3%.
  2. Net income of $685.8 million, or $4.85 diluted EPS, versus $2.33 restated diluted EPS in fiscal 2006.
  3. Restatement adds $96.4 million pre-tax ($65.8 million after tax) of stock-based compensation and payroll tax expense for fiscal 1997–2006, with no effect on reported revenue or cash.
  4. Estimated $50–55 million liability to cover potential Section 409A tax exposure for affected employees, including the CEO and executive officers.
  5. NASDAQ listing non-compliance due to delayed filings; delisting was stayed pending review, and the company is ineligible for Form S-3 for one year.
  6. Returned $1.08 billion through share repurchases in fiscal 2007, completing all authorizations; cash and short-term investments declined.
  7. Acquired about 94% of SEZ Holding AG (single-wafer clean technology) for approximately US$584 million, and funded with a new $250 million term loan in March 2008.

Frequently Asked Questions

  1. Why did Lam Research restate its historical financials?

    An independent committee found that the measurement dates for accounting purposes of certain stock option grants, mainly from fiscal 1997–2005, differed from the recorded grant dates. Under APB Opinion No. 25, intrinsic value at the correct measurement date required additional compensation expense. The committee found no intentional misconduct by management or independent directors.

  2. Did the restatement affect Lam Research's revenue or cash?

    No. The filing states that the adjustments did not affect previously reported revenue, cash, cash equivalents, or short-term investments. The changes relate to non-cash stock-based compensation, related payroll taxes, and tax effects.

  3. What are the main near-term financial and legal risks from the option review?

    Risks include the estimated $50–55 million Section 409A tax make-whole obligation, possible shareholder derivative or class action lawsuits (a stockholder has already sent a demand letter), higher director and officer insurance costs, possible SEC guidance requiring amended filings, and continued NASDAQ listing uncertainty if regulators disagree with the company's accounting.

  4. How strong was Lam Research's operating performance in fiscal 2007?

    Performance was strong. Revenue grew 56% to $2.57 billion, driven by market share gains in dielectric and conductor etch and broad strength across regions. Operating margin expanded to 30.3% from 24.6%, and operating cash flow more than doubled to $823.6 million. Backlog was about $643 million at year end.

  5. What did the SEZ acquisition and new debt mean for the balance sheet?

    Lam acquired about 94% of SEZ Holding AG for roughly US$584 million, using a call option to hedge currency exposure. It also refinanced its $250 million LRI facility with a new $250 million term loan from ABN AMRO maturing in 2010, and entered into operating leases with BNP Paribas for Fremont and Livermore facilities that carry guarantees of up to $165 million. These changes add integration risk, higher debt service, and off-balance-sheet obligations.